^
BIOMARKER:

MAP2K2 mutation

i
Other names: MAP2K2, MEK2, PRKMK2, Mitogen-activated protein kinase kinase 2
Entrez ID:
Related biomarkers:
MAP2K2 mutation
Melanoma
CTLA4 inhibitor
Sensitive: C3 – Early Trials
MAP2K2 mutation
Melanoma
dabrafenib
Resistant: D – Preclinical
MAP2K2 mutation
Melanoma
trametinib
Resistant: D – Preclinical